Aurobindo Pharma Shares Gained Nearly 4 Percent After Company Launches Sensipar

Aurobindo Pharma shares gained nearly 4 percent after company launches Sensipar generic in the US market. The drug is used for patients chronic kidney disease.

"We expect to see a gradual improvement as GDP growth numbers have bottomed out. Crude oil at $75 a barrel is a risk for India," Bharat Iyer of JPMorgan said in an interview to CNBC-TV18,

The brokerage is neutral on IT sector as growth is stable but valuations are expensive while it is underweight on pharma sector.

For more information ✆ +91- 6232578593 or visit www.moneymarketmanthan.com